These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7977090)

  • 1. Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris.
    de Vries RJ; Dunselman PH; van Veldhuisen DJ; van den Heuvel AF; Wielenga RP; Lie KI
    Am J Cardiol; 1994 Dec; 74(12):1201-6. PubMed ID: 7977090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
    Chen YH; Ding PY; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris.
    Svendsen JH; Aldershvile J; Abildgaard U; Amtorp O
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):358-63. PubMed ID: 2476613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group.
    Glasser SP
    Am J Cardiol; 1997 Dec; 80(12):1546-50. PubMed ID: 9416933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
    Walker JM; Curry PV; Bailey AE; Steare SE
    Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
    Nordlander R; Walter M
    Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.
    Shimada K; Sunayama S; Nakazato K; Satoh H; Kusama Y; Kawakubo K; Daida H
    Int Heart J; 2006 Sep; 47(5):695-705. PubMed ID: 17106140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor tolerance and limited effects of isosorbide-5-mononitrate in microvascular angina.
    Wu M; Villano A; Russo G; Di Franco A; Stazi A; Lauria C; Sestito A; Lanza GA; Crea F
    Cardiology; 2015; 130(4):201-6. PubMed ID: 25790943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
    Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
    Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
    Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
    Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and tolerability of felodipine and nifedipine in stable angina refractory to beta-blocker therapy].
    Mazzotta G; Falcidieno M; Ravera E; Vecchio C
    G Ital Cardiol; 1996 Apr; 26(4):407-17. PubMed ID: 8707025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Felodipine in addition to beta-adrenergic blockade for angina pectoris. a multicentre, randomized, placebo-controlled trial.
    Rønnevik PK; Silke B; Ostergaard O
    Eur Heart J; 1995 Nov; 16(11):1535-41. PubMed ID: 8881845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
    Uusitalo A
    Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrate-induced headache in patients with stable angina pectoris: beneficial effect of starting on a low dosage. 5-ISMN headache study group.
    Cleophas TJ; Niemeyer MC; van der Wall EE; van der Meulen J
    Angiology; 1996 Jul; 47(7):679-85. PubMed ID: 8686962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antianginal effect of isosorbide-5-mononitrate in patients with chronic stable angina pectoris.
    Yasky J; Ontanilla E; Koch JE
    Cardiology; 1991; 79 Suppl 2():27-30. PubMed ID: 1760826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
    Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
    Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine modifies the acute effects of isosorbide-5-mononitrate in angina pectoris patients evaluated by exercise testing.
    Svendsen JH; Klarlund K; Aldershvile J; Waldorff S
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):320-3. PubMed ID: 2468964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina.
    Hall R; Chong C
    Cardiology; 2001; 96(2):72-7. PubMed ID: 11740135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-anginal efficacy of a controlled-release formulation of isosorbide-5-mononitrate once daily in angina patients on chronic beta-blockade.
    Uusitalo A; Keyriläinen O; Härkönen R; Rautio P; Rehnqvist N; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G
    Acta Med Scand; 1988; 223(3):219-25. PubMed ID: 2895564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 50-mg and 100-mg sustained-release isosorbide mononitrate in the treatment of stable angina pectoris: effects on quality-of-life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group.
    Zwinderman AH; Cleophas TJ; van der Sluijs H; Niemeyer MG; Buunk BP; van der Wall EE
    Angiology; 1999 Dec; 50(12):963-9. PubMed ID: 10609762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.